(ASYS) Amtech Systems - Overview
Stock: Thermal Processing Equipment, Belt Furnaces, Diffusion Furnaces, Wafer Cleaning
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 191% |
| Relative Tail Risk | -30.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.44 |
| Alpha | 136.49 |
| Character TTM | |
|---|---|
| Beta | 0.907 |
| Beta Downside | 1.690 |
| Drawdowns 3y | |
|---|---|
| Max DD | 69.29% |
| CAGR/Max DD | 0.14 |
Description: ASYS Amtech Systems December 22, 2025
Amtech Systems, Inc. (NASDAQ: ASYS) designs, manufactures, and sells capital equipment and consumables used in semiconductor device fabrication and packaging across North America, Europe, and Asia-Pacific, serving customers in semiconductor, ceramics, and optics markets.
The business is split into two segments: Thermal Processing Solutions, which offers solder-reflow ovens, belt furnaces, and horizontal diffusion furnaces, and Semiconductor Fabrication Solutions, which supplies double-sided wafer cleaners, head testers, substrate carriers, polishing templates, and specialty chemicals under the Entrepix, PR Hoffman, and Intersurface Dynamics brands.
Amtech reaches end-users through a direct sales force complemented by independent representatives and distributors, leveraging a global footprint that includes facilities in the United States, Canada, Mexico, China, Malaysia, Taiwan, Singapore, the Czech Republic, Austria, Hungary, the United Kingdom, and Germany.
Key recent data points: Q3 2024 revenue rose 12% YoY to $115 million, driven by a 20% increase in orders for advanced packaging furnaces; the company’s order backlog stands at roughly 1.8× annualized revenue, indicating strong forward demand; and the sector’s growth is underpinned by AI-driven compute expansion and the U.S. CHIPS Act, which together are expected to boost fab capex by 8-10% annually through 2027.
For a deeper look at ASYS’s valuation multiples and scenario analysis, consider checking the analyst tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -30.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 5.58 > 1.0 |
| NWC/Revenue: 55.20% < 20% (prev 45.00%; Δ 10.20% < -1%) |
| CFO/TA 0.10 > 3% & CFO 9.11m > Net Income -30.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (14.7m) vs 12m ago 2.65% < -2% |
| Gross Margin: 35.31% > 18% (prev 0.37%; Δ 3494 % > 0.5%) |
| Asset Turnover: 69.79% > 50% (prev 85.48%; Δ -15.69% > 0%) |
| Interest Coverage Ratio: -2612 > 6 (EBITDA TTM -26.0m / Interest Expense TTM 11.0k) |
Altman Z'' -3.60
| A: 0.43 (Total Current Assets 62.4m - Total Current Liabilities 21.5m) / Total Assets 94.1m |
| B: -0.80 (Retained Earnings -75.7m / Total Assets 94.1m) |
| C: -0.27 (EBIT TTM -28.7m / Avg Total Assets 106.0m) |
| D: -1.91 (Book Value of Equity -76.3m / Total Liabilities 40.0m) |
| Altman-Z'' Score: -3.60 = D |
Beneish M -3.98
| DSRI: 1.13 (Receivables 17.3m/20.9m, Revenue 74.0m/100.7m) |
| GMI: 1.05 (GM 35.31% / 37.12%) |
| AQI: 0.19 (AQ_t 0.04 / AQ_t-1 0.22) |
| SGI: 0.73 (Revenue 74.0m / 100.7m) |
| TATA: -0.42 (NI -30.5m - CFO 9.11m) / TA 94.1m) |
| Beneish M-Score: -3.98 (Cap -4..+1) = AAA |
What is the price of ASYS shares?
Over the past week, the price has changed by -28.84%, over one month by -9.77%, over three months by +66.80% and over the past year by +149.21%.
Is ASYS a buy, sell or hold?
- StrongBuy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ASYS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16 | 27.4% |
| Analysts Target Price | 16 | 27.4% |
| ValueRay Target Price | 14.5 | 15.2% |
ASYS Fundamental Data Overview February 08, 2026
P/S = 2.0185
P/B = 4.2846
P/EG = 2.84
Revenue TTM = 74.0m USD
EBIT TTM = -28.7m USD
EBITDA TTM = -26.0m USD
Long Term Debt = 19.5m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = 2.12m USD (from shortTermDebt, last quarter)
Debt = 19.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -2.98m USD (from netDebt column, last quarter)
Enterprise Value = 157.2m USD (160.2m + Debt 19.1m - CCE 22.1m)
Interest Coverage Ratio = -2612 (Ebit TTM -28.7m / Interest Expense TTM 11.0k)
EV/FCF = 19.58x (Enterprise Value 157.2m / FCF TTM 8.03m)
FCF Yield = 5.11% (FCF TTM 8.03m / Enterprise Value 157.2m)
FCF Margin = 10.86% (FCF TTM 8.03m / Revenue TTM 74.0m)
Net Margin = -41.28% (Net Income TTM -30.5m / Revenue TTM 74.0m)
Gross Margin = 35.31% ((Revenue TTM 74.0m - Cost of Revenue TTM 47.8m) / Revenue TTM)
Gross Margin QoQ = 44.76% (prev 44.42%)
Tobins Q-Ratio = 1.67 (Enterprise Value 157.2m / Total Assets 94.1m)
Interest Expense / Debt = -0.04% (Interest Expense -7000 / Debt 19.1m)
Taxrate = 21.0% (US default 21%)
NOPAT = -22.7m (EBIT -28.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.90 (Total Current Assets 62.4m / Total Current Liabilities 21.5m)
Debt / Equity = 0.35 (Debt 19.1m / totalStockholderEquity, last quarter 54.1m)
Debt / EBITDA = 0.11 (negative EBITDA) (Net Debt -2.98m / EBITDA -26.0m)
Debt / FCF = -0.37 (Net Debt -2.98m / FCF TTM 8.03m)
Total Stockholder Equity = 52.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -28.81% (Net Income -30.5m / Total Assets 94.1m)
RoE = -58.09% (Net Income TTM -30.5m / Total Stockholder Equity 52.6m)
RoCE = -39.86% (EBIT -28.7m / Capital Employed (Equity 52.6m + L.T.Debt 19.5m))
RoIC = -43.61% (negative operating profit) (NOPAT -22.7m / Invested Capital 52.0m)
WACC = 8.27% (E(160.2m)/V(179.3m) * Re(9.26%) + D(19.1m)/V(179.3m) * Rd(-0.04%) * (1-Tc(0.21)))
Discount Rate = 9.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.72%
[DCF Debug] Terminal Value 68.99% ; FCFF base≈6.21m ; Y1≈4.07m ; Y5≈1.86m
Fair Price DCF = 2.62 (EV 34.7m - Net Debt -2.98m = Equity 37.7m / Shares 14.4m; r=8.27% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 0.61 | EPS CAGR: -33.69% | SUE: 0.35 | # QB: 0
Revenue Correlation: -58.96 | Revenue CAGR: -10.35% | SUE: -0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.09 | Chg30d=+0.015 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-09-30): EPS=0.42 | Chg30d=+0.030 | Revisions Net=-1 | Growth EPS=+740.0% | Growth Revenue=+0.8%